RD
Ronald J Daniels (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $3.9M of BBIO (61,031 sh × $63.72, as filed), executed Nov 6 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.9M
shares × price, as filed
Last traded
Nov 6 2025
Filed Nov 7 2025
Median ADV $293.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
BBIORecent filings
BBIOSALE
BridgeBio Pharma, Inc.
View filing →
$3.9M61,031 sh × $63.72
Exec Nov 6 2025
Filed Nov 7 2025 · 5:30 PM ET